Back to all news

GE HealthCare’s True Definition DL Receives FDA Clearance for CT Imaging

GE HealthCare’s True Definition DL Receives FDA Clearance for CT Imaging

GE HealthCare's True Definition DL, a deep learning-based CT image reconstruction tool, has received FDA 510(k) clearance.

Key Details

  • 1True Definition DL is a deep learning CT image reconstruction solution from GE HealthCare.
  • 2The AI tool increases image resolution without requiring workflow or protocol changes.
  • 3It improves visualization of fine anatomical structures such as small airways and pulmonary nodules.
  • 4Designed to avoid longer scan times and higher radiation doses typically needed for detailed images.
  • 5Available for both field CT upgrades and new installations on the Revolution Apex and Revolution Vibe platforms.
  • 6Adds to GE’s portfolio of cleared DL-based imaging solutions, including TrueFidelity DL and True Enhance DL.

Why It Matters

FDA clearance of True Definition DL may enhance the adoption of deep learning reconstruction in CT imaging, potentially leading to better diagnostic confidence and outcomes with greater efficiency. This underscores the expanding role of AI in everyday radiology workflows.
Radiology Business

Source

Radiology Business

View all from this source

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.